ASP ISOTOPES INC - ASPI announces QLEs confidential submission of draft registration statement for proposed initial public offering

ASPI announces QLE’s confidential submission of draft registration statement for proposed initial public offering

ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO

("ASPI" or "the Company")


ASPI ANNOUNCES QUANTUM LEAP ENERGY'S CONFIDENTIAL SUBMISSION OF DRAFT REGISTRATION STATEMENT 
FOR PROPOSED INITIAL PUBLIC OFFERING


WASHINGTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) today
announced that its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE"), has confidentially
submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission (the
"SEC") relating to the proposed initial public offering of QLE's Class A common stock. The number of
shares to be offered and the price range for the proposed offering have not yet been determined. The
proposed initial public offering remains subject to the completion of the SEC review process as well as
market and other conditions.

This press release is being issued pursuant to, and in accordance with, Rule 135 promulgated under
the Securities Act of 1933, as amended (the "Securities Act"). This press release does not constitute an
offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy,
or any sales of securities will be made in accordance with the registration requirements of the Securities
Act.

About ASP Isotopes Inc

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development
of technology and processes to produce isotopes for use in multiple industries. The Company employs
proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial
focus is on producing and commercializing highly enriched isotopes for the healthcare and technology
industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum
Enrichment technology that the Company is developing. The Company has isotope enrichment facilities
in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass
(light isotopes).

Contacts

Jason Assad– Investor relations
Email: Jassad@aspisotopes.com


13 November 2025

Sponsor
Valeo Capital Proprietary Limited

Date: 13-11-2025 09:08:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.